# OnCo record tac-001 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/tac-001/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "tac-001" ;
  schema:name "TAC-001"@en ;
  schema:alternateName "CD22 TRAAC"@en ;
  schema:description "TAC-001 is an experimental toll-like receptor agonist antibody conjugate from Tallac Therapeutics, in phase 1 trials for advanced or metastatic solid tumours and cholangiocarcinoma."@en ;
  schema:url <https://onco.cc/drugs/tac-001/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.tallactherapeutics.com/news/tallac-presents-first-clinical-data-for-tac-001-at-sitc-2023/>, <https://www.tallactherapeutics.com/news/fda-grants-fast-track-designation-to-tac-001/>, <https://clinicaltrials.gov/study/NCT05399654>, <https://clinicaltrials.gov/search?intr=TAC-001> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Toll-like receptor agonist antibody conjugate (TRAAC)" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:targets <https://onco.cc/targets/cd22/> ;
  onco:companies <https://onco.cc/companies/tallac-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct05399654/> .